Darvon/Darvocet Recall

Darvon/Darvocet Recall 2016-06-03T11:41:48+00:00

In November, 2010, the Food and Drug Administration (FDA) initiated a recall of the popular prescription painkiller medications Darvon and Darvocet. The active ingredient in each of these drugs is propoxyphene. The primary difference between Darvon and Darvocet is that Darvocet contains acetaminophen as well. The FDA stated the reason behind the recall was that Darvon and Darvocet are associated with many serious risks without providing substantial enough benefits to offset these risks.

Doctors have been notified of the recall, and moving forward, they will not be prescribing these drugs to patients. If you have been taking Darvon, Darvocet, or a generic form of these drugs, you should contact your doctor immediately to discuss alternatives which will be safer.

The Milwaukee pharmaceutical injury attorneys at Techmeier Law Firm are currently accepting cases from individuals who have suffered serious injuries as a result of taking Darvon and Darvocet. If you have a Darvon claim, our attorneys can help you receive the compensation you deserve.

Darvon/Darvocet Risks

Darvon and Darvocet have been prescribed to help alleviate mild to moderate post-surgical pain for more than 50 years. During this time, more than 22 million people have taken this drug following their surgical procedure.

As early as the late 1970s, there has been substantial evidence demonstrating that Darvon and Darvocet are associated with serious side effects. In 1978, the consumer watch group Public Citizen filed a petition with the FDA requesting that Darvon and Darvocet be recalled due to their risk of:

  • Serious, potentially fatal heart conditions
  • Addiction
  • Suicidal tendencies

Furthermore, research indicated that propoxyphene, the active ingredient in these dangerous drugs, was only minimally more effective than over-the-counter alternatives such as acetaminophen in alleviating post-surgical pain.

Since, 1981, there have been 2,110 reports of accidental deaths linked to Darvon and Darvocet. The majority of these wrongful deaths were the result of heart rhythm irregularities.

Due to these serious issues, Darvon and Darvocet were recalled from the U.K. market in 2005. In 2006, Public Watch filed another petition with the FDA to have these drugs pulled from the U.S. market. However, the FDA once again failed to take action. As a result, Public Watch filed a lawsuit against the FDA in 2008, prompting the agency to create an advisory panel to evaluate the safety of Darvon and Darvocet. In January 2009, the FDA advisory panel recommended that Darvon and Darvocet be recalled due to their risk of fatal heart conditions. Almost two years later, the FDA finally initiated a recall.

Techmeier Law Firm Can Help You

If you have lost a loved one due to a fatal heart condition caused by Darvon or Darvocet, you may be entitled to receive compensation for your damages. The pharmaceutical injury lawyers at Techmeier Law Firm can protect your rights so that you receive the settlement to which you are entitled. We have the resources of a large national law firm, enabling us to effectively battle the high powered legal teams employed by pharmaceutical companies. We will fight aggressively through every step of the process, and we have the skills to pursue your claim in court if necessary.

Please contact our Milwaukee pharmaceutical injury lawyers today to schedule your free initial consultation at Techmeier Law Firm.